RPRX Royalty Pharma plc

NEUTRAL Impact: 3/10 Insider Cluster (2 insiders)
Horizon days Filed May 15, 2026 Processed 25d 9h ago
Insider cluster: 2 insiders, $888K total
Latest settled — T+5d ⚠ clustered
RPRX ▲ +3.44% at T+5d
NEUTRAL call ✓ call won +3.44% · α vs SPY +1.82% · entry $52.07 → $53.86
Next anchor: T+20d in 5d
Last close $54.86 (close Jun 8) · +5.36% from $52.07 entry
Entry anchored
May 15, 2026
via day open
T+1d
+0.65%
call +0.65% · α +1.30%
$52.41
settled 23d ago
T+5d
+3.44%
call +3.44% · α +1.82%
$53.86
settled 19d ago
T+20d
call — · α —
in 5d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two insiders at Royalty Pharma sold a combined $888K in open-market sales on May 14, 2026, following the company's Q1 earnings beat and raised guidance reported on May 6. The sales are small relative to the $30.7B market cap (0.003%) and likely reflect routine portfolio diversification after a strong earnings release, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$887.5K
Insiders
2

Actionable Insight

The insider sales are negligible in size and follow a strong earnings report, suggesting no negative read-through. Monitor for any larger insider sales in the coming weeks, but this cluster alone does not warrant action.

Key Facts

  • EVP Urist Marshall sold 13,684 shares at ~$53.06 for $726K on May 14, 2026.
  • Director Norden Gregory sold 3,045 shares at $53.00 for $161K on May 14, 2026.
  • Total insider sales of $888K represent ~0.003% of RPRX's $30.7B market cap.
  • Sales occurred 8 days after RPRX reported Q1 2026 Portfolio Receipts of $925M (+10% YoY) and raised full-year guidance.
  • No open-market purchases were reported in the cluster.

Financial Impact

Total insider sales of $888K, immaterial relative to $30.7B market cap.

insider holdings

Risk Factors

  • Insider sales could accelerate if the stock continues to appreciate post-earnings.
  • No purchases in the cluster provide no bullish signal from insiders.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RPRX-1778877697570
12 reports for RPRX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RPRX — sortable, filterable
Type Now
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 4/10
$55.76 $55.87▲ +0.20%▲ +2.72%$54.86 (−1.61%)
May 28, 2026
12d ago
8-K
NEUTRAL ★ 4/10
$55.76 $54.97▼ −1.42%▼ −1.12%$54.86 (−1.61%)
May 22, 2026
19d ago
Insider Cluster
NEUTRAL ★ 2/10
$54.50 $55.18▲ +1.25%▼ −0.41%$54.86 (+0.66%)
May 15, 2026
25d ago
Insider Cluster
NEUTRAL ★ 3/10
$52.07 $53.86▲ +3.44%▲ +1.82%$54.86 (+5.36%)
May 14, 2026
26d ago
144
NEUTRAL ★ 2/10
$52.85 $54.50▲ +3.12%▲ +2.16%$54.86 (+3.80%)
May 6, 2026
4w ago
8-K
BULLISH ★ 6/10
$50.72 $51.70▲ +1.93%▲ +0.80%$54.86 (+8.16%)
Apr 17, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$50.00 $49.38▼ −1.24%▼ −1.79%$54.86 (+9.72%)
Apr 15, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$48.48 $49.64▲ +2.39%▲ +1.41%$54.86 (+13.16%)
Apr 10, 2026
8w ago
DEFA14A
NEUTRAL ★ 2/10
$48.43 $49.30▲ +1.80%▼ −1.50%$54.86 (+13.28%)
Mar 30, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$46.37 $46.87▲ +1.08%▼ −3.22%$54.86 (+18.31%)
Showing 10 of 12

US Market Status

Market Closed — Opens in 7h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access